The updated manufacturing technique eliminates posterior patches and smooths implant edges, aiming to provide surgeons with a more refined tool for body contouring. According to CEO Prof. Dr. Karsten Hemmrich, the shift underscores the company’s long-term investment in polyurethane technology and its commitment to evolving product standards alongside clinical practice.

POLYTECH has initiated a phased rollout of the updated implants across select global markets, with further availability contingent on local regulatory requirements and production capacity. Surgeons seeking technical specifications or regional distribution schedules are advised to coordinate directly with local company representatives. The development remains anchored in the company's Dieburg headquarters, where all manufacturing and research operations are consolidated.